Siewers David 4
4 · SELECTA BIOSCIENCES INC · Filed Sep 22, 2017
Insider Transaction Report
Form 4
Siewers David
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2017-09-20$0.63/sh+2,194$1,382→ 2,194 total - Sale
Common Stock
2017-09-20$20.00/sh−2,194$43,880→ 0 total - Exercise/Conversion
Employee Stock Option (right to buy)
2017-09-20−14,230→ 5,000 totalExercise: $0.63Exp: 2021-02-16→ Common Stock (14,230 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2017-09-20−2,194→ 0 totalExercise: $0.63Exp: 2020-09-06→ Common Stock (2,194 underlying) - Exercise/Conversion
Common Stock
2017-09-20$0.63/sh+14,230$8,965→ 14,230 total - Sale
Common Stock
2017-09-20$20.00/sh−14,230$284,600→ 0 total
Footnotes (2)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2016.
- [F2]All shares underlying this option are fully vested.